Lowey Dannenberg P.C. has filed a class action lawsuit against DexCom, Inc. (NASDAQ: DXCM) alleging violations of federal securities laws. The lawsuit claims that DexCom made unauthorized material design changes to its G6 and G7 devices, rendering them less reliable and posing health risks, which led to a precipitous decline in DexCom's stock value. Investors who suffered losses exceeding $100,000 are encouraged to contact the firm.

德康医疗

<p>Lowey Dannenberg P.C. 已对 DexCom, Inc. (NASDAQ: DXCM) 提起集体诉讼，指控其违反联邦证券法。诉讼称，DexCom 对其 G6 和 G7 设备进行了未经授权的重大设计更改，导致设备可靠性降低并带来健康风险，从而导致 DexCom 股票价值急剧下跌。遭受超过 $100,000 损失的投资者被鼓励与该公司联系</p>

Lowey Dannenberg 通知德康医疗公司（“德康医疗” 或